Daniel Moreno B.
- Country
- Sweden
- Department
- Department of Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 12 partner sites.
Specializations
Hematologic Malignancies
The investigator concentrates on malignant disorders of the blood and marrow, encompassing both myeloid and lymphoid neoplasms.
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Multiple Myeloma
- Acute Lymphoblastic Leukemia
Therapeutic strategies include targeted agents, immunotherapies and combination regimens aimed at improving survival.
Stem Cell Transplantation & Graft‑Versus‑Host Disease
Research addresses the application of hematopoietic stem cell transplantation and the management of post‑transplant immune complications.
- Allogeneic Hematopoietic Stem Cell Transplantation
- Chronic Graft‑Versus‑Host Disease
- Acute Graft‑Versus‑Host Disease
- Transplant Rejection
- Immunomodulatory Therapies
Efforts focus on optimizing conditioning regimens and mitigating graft‑related morbidity.
Renal Immunology & Proteinuric Kidney Diseases
Investigation targets immune‑mediated kidney disorders characterized by protein leakage and progressive loss of renal function.
- Immunoglobulin A Nephropathy
- Chronic Kidney Disease
- Proteinuria
- Lupus Nephritis
- Focal Segmental Glomerulosclerosis
Therapeutic aims include preservation of glomerular filtration and reduction of inflammatory injury.
Metabolic Liver Disease and Associated Disorders
The focus is on liver conditions linked to metabolic dysfunction and their systemic sequelae.
- Non‑Alcoholic Steatohepatitis
- Metabolic Dysfunction‑Associated Steatotic Liver Disease
- Obesity
- Type 2 Diabetes
- Dyslipidemia
Research seeks interventions that halt disease progression and mitigate cardiovascular risk.
Systemic Autoimmune and Vascular Disorders
Work includes diseases where immune dysregulation drives vascular injury and systemic inflammation.
- ANCA‑Associated Vasculitis
- Atherosclerotic Cardiovascular Disease
- Systemic Lupus Erythematosus
- Primary Sjögren's syndrome
- Antiphospholipid Antibody Syndrome
Therapeutic exploration emphasizes immune modulation and vascular protection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.